TransMedics Group, Inc. Payments for Derivative Instrument, Financing Activities
TransMedics Group, Inc. (TMDX) reported Payments for Derivative Instrument, Financing Activities of $52.07 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForDerivativeInstrumentFinancingActivities · last filed 2023-11-08
- TransMedics Group, Inc. payments for derivative instrument, financing activities for the quarter ending 2023-09-30 was $0.00.
| Period end | Payments for Derivative Instrument, Financing Activities 3 month | Payments for Derivative Instrument, Financing Activities 6 month | Payments for Derivative Instrument, Financing Activities 9 month |
|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $52.07M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $52.07M 10-Q · filed 2023-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |